| Title : Initial phase 2 trial of a nicotinic agonist in schizophrenia - Freedman_2008_Am.J.Psychiatry_165_1040 |
| Author(s) : Freedman R , Olincy A , Buchanan RW , Harris JG , Gold JM , Johnson L , Allensworth D , Guzman-Bonilla A , Clement B , Ball MP , Kutnick J , Pender V , Martin LF , Stevens KE , Wagner BD , Zerbe GO , Soti F , Kem WR |
| Ref : Am J Psychiatry , 165 :1040 , 2008 |
| Abstract : Freedman_2008_Am.J.Psychiatry_165_1040 |
| ESTHER : Freedman_2008_Am.J.Psychiatry_165_1040 |
| PubMedSearch : Freedman_2008_Am.J.Psychiatry_165_1040 |
| PubMedID: 18381905 |
Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, Zerbe GO, Soti F, Kem WR (2008)
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Am J Psychiatry
165 :1040
Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, Zerbe GO, Soti F, Kem WR (2008)
Am J Psychiatry
165 :1040